Tech Company Financing Transactions
Immunomic Therapeutics Funding Round
Immunomic Therapeutics secured a $2.7 million venture capital round on 6/13/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/13/2013
Transaction Type
Debt
Amount
$2,729,500
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15010 Broschart Rd. 250
Hershey, MD 20850
USA
Hershey, MD 20850
USA
Phone
Website
Email Address
Overview
Immunomic Therapeutics, Inc. is developing next generation vaccines focusing on allergy immunotherapy. The Company's first vaccine will be for Japanese Red Cedar, JRC-LAMP-vax.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/13/2013: Iconology venture capital transaction
Next: 6/13/2013: TrueVision Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs